Clinical Laboratories

Courtesy of Clinical OMICs - Molecular Diagnostics in Personalized Medicine Johns Hopkins researchers have published new data that suggests epigenetic changes controlling how DNA operates, provides survival advantages to a subset of...

Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach. A billion dollars sounds like a lot of money. But when your ambitions are as big as the...

This story from GE Reports was originally published during RSNA last year to help promote their new mammography equipment and referenced the good work being done at Gustave Roussy Cancer Center in a southern suburb of Paris.  But same day...

One of the best parts of this job, being a news gatherer and news distributor for all of you is getting to know about several great companies and the dedicated people who make them go. One of those companies is Indica Labs based in New...

  In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive...

I received a lot of feedback offline about Part 1 of this post (see: “To Sign Out or Not to Sign Out? Part 1” ) from a number of pathologists echoing my sentiments on the issue of turnaround time in general and needs/expectations from...